Advancing Pathology using AI with Joseph Mossel Co-founder & CEO of Ibex

In this episode of From Lab to Launch by Qualio we interview Joseph Mossel, CEO and co-founder of Ibex Medical Analytics. Joseph shares his journey from computer science to leading a transformative AI-driven company in pathology. Founded in 2016, Ibex aims to provide accurate, timely, and personalized cancer diagnoses using AI technology. Joseph discusses the challenges and insights from deploying AI in clinical settings, the importance of partnerships, and the company"s vision for the next few years. Tune in to learn how Ibex"s innovations are reshaping cancer diagnostics and making a significant impact on patient outcomes. https://ibex-ai.com/  https://www.linkedin.com/in/yossimossel/  00:00 Introduction to the Podcast 00:26 Meet Joseph Mossel, CEO of Ibex 01:14 The Founding and Vision of Ibex 05:59 Ibex"s AI Technology and Its Impact 07:41 Challenges and Overcoming Them 09:54 AI in Cancer Diagnostics 15:12 Future of AI in Pathology 17:15 Partnerships and Collaborations 19:58 Advice for Labs and Entrepreneurs 23:29 Ensuring AI Reliability and Quality 25:48 Fun and Final Thoughts Qualio website: https://www.qualio.com/ Previous episodes: https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez